Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 7,995Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Catalent Micron Technologies, Inc.

02 1Hetero Labs Limited

03 1Jiangsu Hengrui Pharmaceuticals Co., Ltd.

04 2Natco Pharma Limited

05 1ScinoPharm Taiwan Ltd.

06 1Sicor de Mexico S.A. de C.V

07 1Synthimed Labs Private Limited

08 1Zhejiang Hisun Pharmaceutical Co., Ltd.

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

02

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

LETROZOLE

NDC Package Code : 68554-0039

Start Marketing Date : 1997-07-25

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

03

Arvo
Not Confirmed
arrow

04

Arvo
Not Confirmed
arrow

05

Arvo
Not Confirmed
arrow

06

Arvo
Not Confirmed
arrow

07

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

LETROZOLE

NDC Package Code : 63592-3376

Start Marketing Date : 2018-10-19

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (100kg/100kg)

Marketing Category : BULK INGREDIENT

blank

09

Arvo
Not Confirmed
arrow

Looking for 112809-51-5 / Letrozole API manufacturers, exporters & distributors?

Letrozole manufacturers, exporters & distributors 1

60

PharmaCompass offers a list of Letrozole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Letrozole manufacturer or Letrozole supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Letrozole manufacturer or Letrozole supplier.

PharmaCompass also assists you with knowing the Letrozole API Price utilized in the formulation of products. Letrozole API Price is not always fixed or binding as the Letrozole Price is obtained through a variety of data sources. The Letrozole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Letrozole

Synonyms

112809-51-5, Femara, 4,4'-((1h-1,2,4-triazol-1-yl)methylene)dibenzonitrile, Letrozol, Cgs 20267, Cgs-20267

Cas Number

112809-51-5

Unique Ingredient Identifier (UNII)

7LKK855W8I

About Letrozole

A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women.

H020 Manufacturers

A H020 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of H020, including repackagers and relabelers. The FDA regulates H020 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. H020 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of H020 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

H020 Suppliers

A H020 supplier is an individual or a company that provides H020 active pharmaceutical ingredient (API) or H020 finished formulations upon request. The H020 suppliers may include H020 API manufacturers, exporters, distributors and traders.

click here to find a list of H020 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

H020 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing H020 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for H020 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture H020 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain H020 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a H020 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of H020 suppliers with NDC on PharmaCompass.

H020 Manufacturers | Traders | Suppliers

H020 Manufacturers, Traders, Suppliers 1
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.